GE HealthCare Technologies SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 28, 2026, 6:25 a.m. ETView on SEC.gov
Results of operations and financial condition · Departure/appointment of directors or officers · Financial statements and exhibits
AI summary, unreviewedGE HealthCare beats Q3 2026 estimates with adjusted EPS of $1.34 vs $1.20 consensus and revenue of $5.51 billion vs $5.35 billion, raises FY2026 adjusted EPS guidance to $4.95-$5.05; CEO of Patient Care Solutions to resign
8-KSept. 22, 2026, 4:07 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KAug. 18, 2026, 9:03 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Financial statements and exhibits
8-KJuly 29, 2026, 6:27 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
8-KJuly 29, 2026, 6:25 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits